These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30385230)

  • 1. Long-term Healthcare of People with Disorders of Sex Development: Predictors of Pubertal Outcomes of Partial Androgen Insensitivity Syndrome - Authors' Reply.
    Lek N; Tadokoro-Cuccaro R; Hughes I
    EBioMedicine; 2018 Nov; 37():31. PubMed ID: 30385230
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term healthcare of people with disorders of sex development: Predictors of pubertal outcomes of partial androgen insensitivity syndrome.
    Fukami M
    EBioMedicine; 2018 Nov; 37():29-30. PubMed ID: 30337249
    [No Abstract]   [Full Text] [Related]  

  • 3. Androgen insensitivity syndrome.
    Mendoza N; Motos MA
    Gynecol Endocrinol; 2013 Jan; 29(1):1-5. PubMed ID: 22812659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen insensitivity syndrome.
    Williams DM; Patterson MN; Hughes IA
    Arch Dis Child; 1993 Mar; 68(3):343-4. PubMed ID: 8466234
    [No Abstract]   [Full Text] [Related]  

  • 5. [Disorders of sex differentiation with regard to male phenotype].
    Kula K
    Endokrynol Pol; 1984; 35(6):331-44. PubMed ID: 6536471
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical variations of testicular intersexuality in a family.
    Gardó S; Papp Z
    J Med Genet; 1974 Sep; 11(3):267-70. PubMed ID: 4431032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of complete androgen insensitivity syndrome with a novel androgen receptor mutation.
    Chin VL; Sheffer-Babila S; Lee TA; Tanaka K; Zhou P
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1145-51. PubMed ID: 23329762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late diagnosis of complete androgen insensitivity syndrome and transmission/carriers of the condition in a family with mutation c.2495G> T p.(Arg832Leu) in exon 7 of the androgen receptor gene: genetic, clinical and ethical aspects.
    Pomahacova R; Zamboryova J; Paterova P; Krepelova A; Subrt I; Jaklova R; Vohradska P; Hrdonkova E; Sykora J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Dec; 163(4):379-382. PubMed ID: 30401990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 46,XY disorders of sex development--the undermasculinised male with disorders of androgen action.
    Werner R; Grötsch H; Hiort O
    Best Pract Res Clin Endocrinol Metab; 2010 Apr; 24(2):263-77. PubMed ID: 20541151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex hormone-binding globulin response to the anabolic steroid stanozolol: evidence for its suitability as a biological androgen sensitivity test.
    Sinnecker G; Köhler S
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1195-200. PubMed ID: 2723028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting puberty in partial androgen insensitivity syndrome: Use of clinical and functional androgen receptor indices.
    Lek N; Tadokoro-Cuccaro R; Whitchurch JB; Mazumder B; Miles H; Prentice P; Bunch T; Zielińska K; Metzler V; Mongan NP; Heery DM; Hughes IA
    EBioMedicine; 2018 Oct; 36():401-409. PubMed ID: 30316867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The XY female child.
    Dewhurst CJ
    Arch Dis Child; 1970 Aug; 45(242):595-9. PubMed ID: 5528744
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical and genetical studies in testicular feminization syndrome].
    Boczkowski K
    Ginekol Pol; 1969 May; 40(5):549-57. PubMed ID: 5805689
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical, biochemical and morphologic diagnostic markers in an infant male pseudohermaphrodite patient with compound heterozygous mutations (G115D/R246W) in SRD5A2 gene.
    Fernández-Cancio M; Rodó J; Andaluz P; Martínez de Osaba MJ; Rodríguez-Hierro F; Esteban C; Carrascosa A; Audí L
    Horm Res; 2004; 62(5):259-64. PubMed ID: 15528927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sex differentiation disorders: male pseudohermaphroditism. Clinical and etiopathogenetic forms and behavioral aspects].
    Zbranca E; Mogoş V
    Rev Med Chir Soc Med Nat Iasi; 1986; Suppl():295-303. PubMed ID: 3317669
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and molecular aspects of androgen insensitivity.
    Hiort O
    Endocr Dev; 2013; 24():33-40. PubMed ID: 23392093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Male pseudohermaphroditism.
    Kupfer SR; Quigley CA; French FS
    Semin Perinatol; 1992 Oct; 16(5):319-31. PubMed ID: 1485188
    [No Abstract]   [Full Text] [Related]  

  • 18. Male patients with partial androgen insensitivity syndrome: a longitudinal follow-up of growth, reproductive hormones and the development of gynaecomastia.
    Hellmann P; Christiansen P; Johannsen TH; Main KM; Duno M; Juul A
    Arch Dis Child; 2012 May; 97(5):403-9. PubMed ID: 22412043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype versus phenotype in families with androgen insensitivity syndrome.
    Boehmer AL; Brinkmann O; Brüggenwirth H; van Assendelft C; Otten BJ; Verleun-Mooijman MC; Niermeijer MF; Brunner HG; Rouwé CW; Waelkens JJ; Oostdijk W; Kleijer WJ; van der Kwast TH; de Vroede MA; Drop SL
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4151-60. PubMed ID: 11549642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Long-Term Outcome of Boys With Partial Androgen Insensitivity Syndrome and a Mutation in the Androgen Receptor Gene.
    Lucas-Herald A; Bertelloni S; Juul A; Bryce J; Jiang J; Rodie M; Sinnott R; Boroujerdi M; Lindhardt Johansen M; Hiort O; Holterhus PM; Cools M; Guaragna-Filho G; Guerra-Junior G; Weintrob N; Hannema S; Drop S; Guran T; Darendeliler F; Nordenstrom A; Hughes IA; Acerini C; Tadokoro-Cuccaro R; Ahmed SF
    J Clin Endocrinol Metab; 2016 Nov; 101(11):3959-3967. PubMed ID: 27403927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.